Mark McDade is the Co-Founder and Partner of Qiming Venture Partners USA. See sector focus and contact routes.
Mark McDade is the Co-Founder and Partner of Qiming Venture Partners USA, a firm he established in January 2017 after over 30 years of operating experience in healthcare and life sciences, including executive roles at UCB, PDL BioPharma, and Corixa Corporation. His investment thesis targets Seed and Series A stage companies primarily in Consumer Health, Digital Health, and Health IT, with a focus on novel biotherapeutics such as cell and gene therapy. While specific check sizes and lead/follow behavior are not publicly detailed, he actively invests in biopharmaceutical startups and serves on multiple corporate boards. Notable portfolio companies include Icosavax, where he chairs the board, as well as Talaris Therapeutics, LetsGetChecked, and Soda Health, all of which he invests in or oversees. McDade’s distinctive point of view centers on leveraging deep R&D and clinical development expertise to scale biotech ventures, though no public writing or published articles by him are cited in available sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Cambridge.
Investors like Mark McDade · Full investor directory · Investor access · Company funding database